;

19.20 EUR

Opening hours: 09:00 - 05:30 (Central European Standard Time: 12/24/2024 6:05:12 PM)
Exchange closed, opens in 14 hours 54 minutes
1.59 EUR (1.59%)
5.49 EUR (5.49%)
-4.00 EUR (-4.00%)
-4.00 EUR (-4.00%)
6.08 EUR (6.08%)
12.94 EUR (12.94%)

About Philogen S.p.A.

Market Capitalization 753.42M

Philogen S.p.A., a biotechnology company, develops drugs for oncology and chronic inflammatory diseases. It is developing Nidlegy, a combination of the immunocytokines L19IL2 and L19TNF developed intralesional treatment for locoregional melanoma and non-melanoma skin cancers; Fibromun, a human immunomodulatory product consisting of L19 antibody and TNF to treat soft tissue sarcoma, leiomyosarcoma, and glioma; and Darleukin (L19IL2), a human immunostimulatory product consisting of the human L19 antibody fused to the human cytokine interleukin-2 (IL2), which is in phase II clinical trial for the treatment of non-small cell lung cancer. The company is also developing Dodekin, a human immunostimulatory product that comprises vascular targeting antibody fused to interleukin-12 that is in phase I/II clinical trial to treat advanced solid tumors; Dekavil (F8IL10), an anti-inflammatory product, which is in phase II clinical trial for the treatment of chronic inflammatory disorders; Onco IX (PHC-102), a 99mTc labelled small molecule radiotracer for the non-invasive detection of carbonic anhydrase IX (CAIX) expressed on the surface of solid tumors that is in phase 1 clinical trial; and OncoFAP, a small molecule radiotracer for the non-invasive detection of various metastatic solid tumors targeting fibroblast activation protein, which is in phase 1 clinical trial. In addition, it is developing Tripokin, a fully-human immunostimulatory product consisting of tumor necrosis factor and interleukin-2 fused into one molecular entity, which is in preclinical stage. Philogen S.p.A. was founded in 1996 and is based in Siena, Italy.

Headquarters (address)

Piazza La Lizza #7

Siena 53100 SI

Italy

Phone39 05 77206941
Websitehttps://www.philogen.com
Employees174
SectorHealthcare
IndustryBiotechnology
TickerPHIL
ExchangeItalian Stock Exchange
CurrencyEUR
52 week range16.30 - 21.90
Market Capitalization753.42M
P/E trailing1.79K
P/E forward-25.81
Price/Sale192.25
Price/Book9.94
Beta3.00
EPS3.00
EPS Italy (ID:74, base:207) 3.00

CleverShares.com|
2024 ©

1.0.9119.29486